RASAGILINE RATIOPHARM 1 mg, tablet 30 tablets
Active ingredients: Rasagiline mesylate, Rasagiline
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RASAGILINE RATIOPHARM 1 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Jun 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62209971CIP73002055CIP133400930020555Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSILATE DE RASAGILINEcomprimé | 1,56 mg · un comprimé | SA |
| RASAGILINEcomprimé | 1 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.